|
Volumn 22, Issue 3, 2005, Pages 234-237
|
Combination of 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in assessing cardiac sarcoidosis [1]
|
Author keywords
18F FDG PET; MRI; Sarcoidosis; Steroid therapy
|
Indexed keywords
FLUORODEOXYGLUCOSE F 18;
GADOLINIUM;
PREDNISOLONE;
DIAGNOSTIC AGENT;
RADIOPHARMACEUTICAL AGENT;
ADULT;
CASE REPORT;
CLINICAL FEATURE;
DISEASE COURSE;
FEMALE;
FOLLOW UP;
HEART SARCOIDOSIS;
HUMAN;
IMAGE ANALYSIS;
LABORATORY TEST;
LETTER;
NUCLEAR MAGNETIC RESONANCE IMAGING;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
SARCOIDOSIS;
TREATMENT OUTCOME;
CARDIOMYOPATHY;
MIDDLE AGED;
REPRODUCIBILITY;
SCINTISCANNING;
CARDIOMYOPATHIES;
FEMALE;
FLUORODEOXYGLUCOSE F18;
HUMANS;
MAGNETIC RESONANCE IMAGING;
MIDDLE AGED;
POSITRON-EMISSION TOMOGRAPHY;
RADIOPHARMACEUTICALS;
REPRODUCIBILITY OF RESULTS;
SARCOIDOSIS;
|
EID: 27944490013
PISSN: 11240490
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (28)
|
References (6)
|